دورية أكاديمية
Improved Glycemic Control in Adults With Serious Mental Illness and Diabetes With a Behavioral and Educational Intervention.
العنوان: | Improved Glycemic Control in Adults With Serious Mental Illness and Diabetes With a Behavioral and Educational Intervention. |
---|---|
المؤلفون: | Schnitzer K; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Cather C; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Thorndike AN; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Potter K; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Freudenreich O; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., MacLaurin S; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Vilme M; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Dechert A; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Wexler D; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin)., Evins AE; Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin). |
المصدر: | Psychiatric services (Washington, D.C.) [Psychiatr Serv] 2020 Jul 01; Vol. 71 (7), pp. 730-733. Date of Electronic Publication: 2020 Apr 23. |
نوع المنشور: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: American Psychiatric Association Country of Publication: United States NLM ID: 9502838 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9700 (Electronic) Linking ISSN: 10752730 NLM ISO Abbreviation: Psychiatr Serv Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Washington, DC : American Psychiatric Association, c1995- |
مواضيع طبية MeSH: | Glycemic Control* , Patient Education as Topic* , Self Care*, Diabetes Mellitus, Type 2/*therapy , Mental Disorders/*complications, Adult ; Aged ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/mortality ; Diabetes Mellitus, Type 2/psychology ; Female ; Glycated Hemoglobin/analysis ; Glycemic Index ; Humans ; Intention to Treat Analysis ; Male ; Middle Aged |
مستخلص: | Objective: The purpose of this study was to evaluate a 16-week, reverse-integrated care (bringing primary care interventions/services into the psychiatric setting) behavioral and educational group intervention for individuals with serious mental illness and diabetes. Methods: The primary outcome was change in glycated hemoglobin (HbA1c). Secondary outcomes included body mass index (BMI), blood pressure, lipid levels, physical activity, diabetes knowledge, and self-care. Results: Thirty-five participants attended at least one group and were included in a modified intent-to-treat analysis. From baseline to week 16, HbA1c improved, from 7.5±1.6 to 7.1±1.4, p=0.01, and BMI improved, from 33.3±3.8 to 32.9±4.1, p<0.001, as did measures of diabetes knowledge and self-care. One-year follow-up in a subset of participants showed no evidence of rebound in HbA1c. Conclusions: This 16-week behavioral and educational group intervention resulted in improvements in glycemic control, BMI, diabetes knowledge, and self-care. The results warrant larger-scale, controlled trial testing of this intervention to improve diabetes-related health outcomes in those with serious mental illness. |
References: | Schizophr Res. 2006 Sep;86(1-3):36-44. (PMID: 16842977) Clin Rehabil. 2009 Apr;23(4):352-61. (PMID: 19237435) Schizophr Res. 2010 Aug;121(1-3):203-6. (PMID: 20434886) JAMA Psychiatry. 2015 Dec;72(12):1172-81. (PMID: 26509694) Clin Psychol Rev. 2010 Nov;30(7):849-64. (PMID: 20363063) Am Psychol. 2000 Jan;55(1):68-78. (PMID: 11392867) BMJ Open. 2015 Dec 15;5(12):e009010. (PMID: 26671955) J Clin Epidemiol. 2016 Apr;72:66-74. (PMID: 26562052) Psychiatr Serv. 2017 Sep 1;68(9):883-890. (PMID: 28502243) Lancet Psychiatry. 2015 May;2(5):465-476. (PMID: 26360289) |
معلومات مُعتمدة: | K24 DA030443 United States DA NIDA NIH HHS; R25 MH094612 United States MH NIMH NIH HHS |
فهرسة مساهمة: | Keywords: medical morbidity; mortality in psychiatric patients; schizophrenia |
المشرفين على المادة: | 0 (Glycated Hemoglobin A) |
تواريخ الأحداث: | Date Created: 20200424 Date Completed: 20210504 Latest Revision: 20221207 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC7576509 |
DOI: | 10.1176/appi.ps.201900336 |
PMID: | 32321387 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1557-9700 |
---|---|
DOI: | 10.1176/appi.ps.201900336 |